Loading...
Market
How will major healthcare providers and insurers respond to the Bristol-Myers and Sanofi ruling by end of 2024?
5
Resolution / Starting Odds
Stop using Plavix • 33%
Continue using Plavix with warnings • 33%
No change in usage • 34%
Official statements from healthcare providers and insurers
Story
Bristol-Myers and Sanofi Ordered to Pay $916 Million in Hawaii Plavix Case on May 21, 2024
May 22, 2024, 04:12 PM
A judge in Hawaii has ordered Bristol-Myers Squibb Co. and Sanofi to pay more than $916 million to the state for failing to warn non-white patients, particularly those of East Asian or Pacific Island ancestry, about potential health risks associated with their blood thinner Plavix. The ruling, issued on Tuesday, May 21, 2024, increases the companies' liability from an earlier judgment of $834 million.
View original story
Similar markets
Increase production • 33%
Maintain current levels • 33%
Decrease production • 33%
Supportive • 33%
Neutral • 33%
Opposed • 33%
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Bristol-Myers Squibb • 25%
Reformulate supply chains • 33%
Seek exemptions • 33%
Challenge the Act legally • 34%
Supportive statements • 33%
Neutral statements • 34%
Opposition statements • 33%
Support Austin's stance • 33%
Oppose Austin's stance • 33%
No official stance • 34%
No response • 25%
Public support for USAA and Progressive • 25%
Criticism of USAA and Progressive • 25%
Changes in their own policies • 25%
Compliance • 25%
Legal Opposition • 25%
Policy Modification • 25%
No Change • 25%
Full halt on surgeries and treatments • 33%
Partial restrictions • 33%
No change • 33%
More firms investigated • 25%
Sanctions imposed • 25%
No significant actions • 25%
Other actions • 25%
